- Home
- IMNM vs BBT Comparison
IMNM vs BBT Comparison
Compare IMNM & BBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IMNM | BBT |
|---|---|---|
| Founded | 2006 | 1846 |
| Country | United States | United States |
| Employees | N/A | 1000 |
| Industry | Medicinal Chemicals and Botanical Products | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.5B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | IMNM | BBT |
|---|---|---|
| Price | $22.58 | $30.11 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 3 |
| Target Price | $32.10 | ★ $33.33 |
| AVG Volume (30 Days) | ★ 959.3K | 793.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.32% |
| EPS Growth | ★ 51.40 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,941,000.00 | N/A |
| Revenue This Year | N/A | $77.88 |
| Revenue Next Year | $11.91 | $4.31 |
| P/E Ratio | ★ N/A | $29.98 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.15 | $22.81 |
| 52 Week High | $27.65 | $32.00 |
Technical Indicators
Market Signals| Indicator | IMNM | BBT |
|---|---|---|
| Relative Strength Index (RSI) | 49.44 | 50.81 |
| Support Level | $18.98 | $29.17 |
| Resistance Level | $27.14 | $31.95 |
| Average True Range (ATR) | 1.11 | 1.01 |
| MACD | -0.11 | -0.25 |
| Stochastic Oscillator | 45.25 | 36.52 |
Price Performance
Historical ComparisonAbout IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About BBT Beacon Financial Corporation
Beacon Financial Corp operates as a multi-bank holding company. It offers commercial, business, and retail banking services, including a full complement of cash management products, online banking services, and consumer and residential loans.